Pivot Park Screening Centre

What Pivot Park Screening Centre does

Pivot Park Screening Centre is a private contract research organization founded in 2012 and headquartered on the Pivot Park life sciences campus in Oss, Netherlands. Per its firmographic profile, it provides assay development, laboratory automation, and high-throughput screening (HTS) services in support of drug discovery projects, serving biotech and pharmaceutical clients who need outsourced primary or secondary screening capacity. The firm is small (11–50 employees) and operates as a for-profit private company; no funding rounds, investor roster, leadership team, named customers, pricing model, revenue figures, or product catalog were disclosed in the input data.

A material data-integrity caveat applies to the public web footprint. The domain ppscreeningcentre.com — listed as the company's website — currently resolves to a Vietnamese-language real estate and urban-planning news portal branded "Việt Nam Mới / VietnamMoi," operated by a Vietnamese entity (Công ty VietNewsCorp) with Vietnamese phone numbers and a content focus on Hanoi, Ho Chi Minh City and other Vietnamese markets. The Vietnamese site and the Dutch CRO profile are materially inconsistent on virtually every dimension (geography, industry, language, entity name). Two readings are consistent with the evidence: (a) the original Dutch CRO let its domain lapse and a Vietnamese media company acquired/parked it, or (b) the aggregated source data conflated two unrelated entities under one record. Either way, the public web presence does not document the CRO's services, customers, or scientific capabilities, and any investor diligence on PPSC should verify the live corporate web footprint directly.

Name

Pivot Park Screening Centre

Legal name

Công ty VietNewsCorp

Website

https://ppscreeningcentre.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Pivot Park Screening Centre is a private Dutch contract research organization founded in 2012 in Oss, Netherlands, offering assay development, lab automation, and high-throughput screening services for drug discovery projects run by biotech and pharmaceutical clients.

Ownership category

akta.pro rank

Product category

Drug Discovery Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industry

High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)

Keywords

• Drug discovery screening
• Assay development services
• High-throughput screening
• Lab automation services
• Pharmaceutical research services

Headquarters

HQ city

Oss

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Core offering

Pivot Park Screening Centre offers assay development, lab automation, and high-throughput screening (HTS) services for drug discovery projects. Operating as a contract research organization (CRO), the company provides specialized screening infrastructure and scientific expertise to support pharmaceutical and biotechnology R&D programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Assay Development

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Emerging players

• BioAscent Discovery: Scotland-based boutique CRO offering medicinal chemistry, in vitro pharmacology, and assay/screening services. Comparable to PPSC as a smaller European specialist discovery CRO.

Direct peers

• Sygnature Discovery: UK-based specialist drug discovery CRO offering medicinal chemistry, in vitro biology, and HTS/assay services. Comparable to Pivot Park Screening Centre as a focused European discovery CRO serving biotech and pharma sponsors.
• Selvita: Poland-headquartered CRO providing integrated drug discovery, including HTS, assay development, and medicinal chemistry. Comparable to PPSC as a European drug discovery CRO targeting biotech and pharma clients.
• Proteros: Germany-based specialist CRO focused on structure-based drug discovery, assay development, and biophysics. Comparable to PPSC as a boutique European drug discovery services firm.
• Concept Life Sciences (Covalent Bio): UK-based discovery CRO offering medicinal chemistry, in vitro biology, and assay/screening services. Comparable to PPSC as a European specialist serving pharma R&D outsourcing needs.

Broad incumbents

• Evotec: Germany-headquartered global drug discovery CRO with deep HTS, assay development, and integrated discovery platforms. Overlaps directly with PPSC's HTS and assay development offering but operates at vastly greater scale.
• Eurofins Discovery: Part of Eurofins Scientific, offering discovery pharmacology, in vitro profiling, and screening services. Comparable to PPSC as a European-based discovery CRO serving pharma and biotech R&D.
• Pharmaron: China-headquartered global CRO with comprehensive drug discovery services including in vitro biology, HTS, and assay development. Comparable as a competitor in outsourced preclinical and discovery services.
• Charles River Laboratories: Large global CRO with an extensive discovery and safety assessment portfolio including HTS and assay development capabilities. Comparable as a competitor in outsourced drug discovery, though much broader in scope.
• WuXi AppTec: Global CRO/CDMO with large-scale discovery services including HTS, assay biology, and DMPK. Comparable as a competitor in outsourced discovery, though operating globally and at significantly larger scale.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/pivot-park-screening-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pivot Park Screening Centre